Don't quite understand why you think Sept quarterly will be the worst, can you explain further in detail? only facts please.
At this point Overall EBITDA ad NPAT will be similar as still not positive in earnings yet. The impairment will also be a tax deduction. The CR was 50% asset acquisition with extra revenue attached. DXN revenue is up over 200% from last year ($5 mill), if a rate of 50% per quarter is is continued then we should see an additional $2.5 million revenue in Sept quarter $3.75 mill in December then extra $5.63 mill in March and $8.44 mill in July 21 = $25.32 million revenue for 20-21 - That will bring DXN into net profit
DXN Price at posting:
2.2¢ Sentiment: Hold Disclosure: Held
